We are live on ! Find out more
TERN

Terns Pharmaceuticals
TERN

Delisted

TERN was delisted on the 4th of May, 2026.

Back to rankings

103 hedge funds and large institutions have $424M invested in Terns Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

535% more call options, than puts

Call options by funds: $1.58M | Put options by funds: $249K

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

50% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 22

37% more capital invested

Capital invested by funds: $310M → $424M (+$113M)

11% more funds holding

Funds holding: 93 → 103 (+10)

4.63% more ownership

Funds ownership: 101.05% → 105.68% (+4.6%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
103
Holders Change
+10
Holders Change %
+10.75%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
26
Increased
33
Reduced
22
Closed
15
Calls
$1.58M
Puts
$249K
Net Calls
+$1.33M
Net Calls Change
-$749K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$13M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$7.53M
3
VA
VR Adviser
New York
+$7.43M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$5.02M
5
GPP
Great Point Partners
Connecticut
+$3.51M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.87M
3
B
Braidwell
Connecticut
-$2.76M
4
DCM
Driehaus Capital Management
Illinois
-$2.58M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$2.33M +$53.8K +10,184 +3%
Russell Investments Group
27
Russell Investments Group
United Kingdom
$1.8M +$1.47M +277,741 New
JP Morgan Chase
28
JP Morgan Chase
New York
$1.42M -$343K -64,934 -23%
SB
29
Samsara BioCapital
California
$1.31M – – –
IC
30
Ikarian Capital
Texas
$1.07M – – –
N
31
Nuveen
North Carolina
$1.02M +$201K +37,952 +32%
HS
32
HighVista Strategies
Massachusetts
$962K – – –
MA
33
MYDA Advisors
New York
$924K +$753K +142,383 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$779K -$47.3K -8,939 -7%
Charles Schwab
35
Charles Schwab
California
$744K – – –
UBS Group
36
UBS Group
Switzerland
$704K +$460K +86,931 +404%
Goldman Sachs
37
Goldman Sachs
New York
$555K -$918K -173,705 -67%
Barclays
38
Barclays
United Kingdom
$549K +$160K +30,255 +56%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$506K -$57.6K -10,887 -12%
AI
40
Atom Investors
Texas
$481K -$141K -26,632 -26%
Swiss National Bank
41
Swiss National Bank
Switzerland
$441K – – –
AAA
42
Affinity Asset Advisors
New York
$428K -$1.37M -259,000 -80%
Jane Street
43
Jane Street
New York
$418K +$341K +64,453 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$405K +$123K +23,338 +60%
Bank of America
45
Bank of America
North Carolina
$382K +$164K +30,993 +111%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$374K -$8.28K -1,566 -3%
PFCS
47
Pale Fire Capital SE
Czech Republic
$318K +$179K +33,812 +222%
ECM
48
ExodusPoint Capital Management
New York
$309K +$251K +47,540 New
Mirae Asset Global Investments
49
Mirae Asset Global Investments
South Korea
$264K +$571 +108 +0.3%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$240K -$58 -11 -0%
1
2
3 4 5

TERN Hedge Fund Activity: Q4 2023 in Review

103 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Terns Pharmaceuticals (TERN) for Q4 2023, worth a combined $424M — up 37% from $310M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new TERN positions and 15 closed out — a net gain of 11 holders — while 33 added to existing stakes and 22 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $13M. The largest seller was Fidelity Investments, cutting an estimated $11.2M.

  • 103 institutional investors held Terns Pharmaceuticals (TERN) as of Q4 2023, up from 93 in Q3 2023.
  • Funds reported $424M of Terns Pharmaceuticals stock for Q4 2023, up 37% quarter-over-quarter.
  • 26 funds opened new Terns Pharmaceuticals positions in Q4 2023 and 15 closed out, a net change of +11 holders.
  • The largest Terns Pharmaceuticals buyer in Q4 2023 was Morgan Stanley, an estimated $13M added.
  • The largest Terns Pharmaceuticals seller in Q4 2023 was Fidelity Investments, an estimated $11.2M sold.

Based on aggregated 13F filings for Q4 2023.